Evidence map›Paper›PMID 39220239›Full record

ArticleMalaysian family physician : the official journal of the Academy of Family Physicians of Malaysia2024

Metabolic associated fatty liver disease (MAFLD): assessing the knowledge and practice of primary care doctors in Seremban District, Negeri Sembilan.

Kalaivaani Vijan, Athirah Ali, Nur Adhajirin Mohamed Idrus, Priscilla Lourdesamy, Shamini Margammuthu, Suguna Perumal, Cheong Lieng Teng, Imran Ahmad

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kalaivaani VijanMBBS, icFRACGP, Klinik Kesihatan Kuala Pilah Jalan Macpherson, Kampung Tebat Kening, Kuala Pilah, Negeri Sembilan, Malaysia. Email: kalai88_libra@hotmail.com.
Athirah AliMD, icFRACGP, Klinik Kesihatan Salak, Jalan Salak, Sepang, Selangor, Malaysia.
Nur Adhajirin Mohamed IdrusMD, Klinik Kesihatan Mantin, Jalan Besar Mantin, Mantin, Negeri Sembilan, Malaysia.
Priscilla LourdesamyMBBS, Klinik Kesihatan Sikamat, Jalan Tunku Kurshiah Atas, Seremban, Negeri Sembilan, Malaysia.
Shamini MargammuthuMD, Klinik Kesihatan Jelebu, Kuala Klawang, Jelebu, Negeri Sembilan, Malaysia.
Suguna PerumalKlinik Kesihatan Port Dickson, Jalan Seremban Kampung Dhobi, Port Dickson, Negeri Sembilan, Malaysia.
Cheong Lieng TengMBBS, M. Family Medicine, Department of Family Medicine, International Medical University, 126, Jalan Jalil Perkasa 19, Bukit, Jalil, Kuala Lumpur, Malaysia.
Imran AhmadMBBS, M. Family Medicine, Department of Family Medicine, Universiti Sains Malaysia, Kampus, Kesihatan, Jalan Raja Perempuan, Zainab 2, Kota Bharu, Kelantan, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Metabolic-associated fatty liver disease (MAFLD) is the liver manifestation of metabolic syndrome, which is commonly seen in primary care settings. This study aimed to determine the knowledge and practice of primary care physicians regarding MAFLD in Seremban District, Negeri Sembilan. Methods: This cross-sectional study was conducted among medical officers in 14 health clinics in Seremban District, using a validated, self-administered online questionnaire. Results: A total of 240 medical officers from 14 health clinics in Seremban District, participated in this study. Most participants (85.4%) passed the knowledge test. Their practice was acceptable, but only a minority were familiar with non-invasive testing of liver fibrosis (e.g. APRI or FIB-4), medication and specific diet for the treatment of MAFLD. Conclusion: Most primary care physicians in Seremban District are knowledgeable in identifying risk factors and managing patients with MAFLD. However, there are still areas to improve in terms of management, particularly regarding the use of silymarin, vitamin E and pioglitazone.

Indexed as

Fatty liverMalaysiaMetabolic syndromeObesityPrimary care physician

Identifiers

PMID39220239
PMCPMC11366277

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.